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Introduction
Dendritic spines are small protrusions from the dendrite that 
form the postsynaptic component of excitatory synapses. Filo-
podia are recognized as one origin of dendritic spines (for 
reviews see Hering and Sheng, 2001; Ethell and Pasquale, 
2005). During early stages of synaptogenesis, fi  lopodia rapidly 
protrude and retract from dendrites. When dendritic fi  lopodia 
contact presynaptic sites and form synapses, filopodia con-
tract and transform into dendritic spines. Many transmembrane 
receptors and intracellular molecules have been shown to play 
a role in spinogenesis (for reviews see Hering and Sheng, 
2001; Carlisle and Kennedy, 2005; Ethell and Pasquale, 2005; 
Lippman and Dunaevsky, 2005; Tada and Sheng, 2006), in-
cluding syndecan-2.
Syndecan-2 belongs to the syndecan family of transmem-
brane heparan sulfate proteoglycans. By virtue of their heparan 
sulfate modifi  cations, syndecans act as coreceptors for growth 
or differentiation factors, presenting these molecules to spe-
cifi  c receptor tyrosine kinases, including the fi  broblast growth 
factor receptors (Filla et al., 1998). Syndecans also function as 
adhesion molecules that regulate cell migration, cell–cell inter-
actions, and cell–extracellular matrix interactions (Klass et al., 
2000; Beauvais et al., 2004; Reiland et al., 2004). During neural 
development, syndecan-2 expression is elevated during syn-
aptogenesis (Ethell and Yamaguchi, 1999; Hsueh and Sheng, 
1999a). The overexpression of syndecan-2 starting at 1 d in vitro 
(DIV) accelerates spine formation in hippocampal neurons 
examined at 8 DIV (Ethell and Yamaguchi, 1999), suggesting 
a role of syndecan-2 in spinogenesis. Because syndecan-2 over-
expression also promotes fi  lopodia formation in nonneuronal cell 
lines such as COS-1 and Swiss 3T3 (Granes et al., 1999, 2000), 
it is possible that syndecan-2 fi  rst promotes fi  lopodia formation 
and, consequently, transforms fi  lopodia into dendritic spines 
in neurons.
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S
yndecan-2 induced ﬁ  lopodia before spinogenesis; 
therefore, ﬁ  lopodia formation was used here as a 
model to study the early downstream signaling of 
syndecan-2 that leads to spinogenesis. Screening using 
  kinase inhibitors indicated that protein kinase A (PKA) is 
required for syndecan-2–induced ﬁ  lopodia formation in 
both human embryonic kidney cells and hippocampal 
neurons. Because neuroﬁ   bromin, a syndecan-2–binding 
partner, activates the cyclic adenosine monophosphate 
pathway, the role of neuroﬁ  bromin in syndecan-2–induced 
ﬁ  lopodia formation was investigated by deletion mutant 
analysis, RNA interference, and dominant-negative mutant. 
The results showed that neurofibromin mediates the 
syndecan-2 signal to PKA. Among actin-associated pro-
teins, Enabled (Ena)/vasodilator-stimulated phosphopro-
tein (VASP) were predicted as PKA effectors downstream 
of syndecan-2, as Ena/VASP, which is activated by PKA, 
induces actin polymerization. Indeed, when the activities 
of Ena/VASP were blocked, syndecan-2 no longer in-
duced ﬁ  lopodia formation. Finally, in addition to ﬁ  lopodia 
formation, neuroﬁ   bromin and Ena/VASP contributed to 
spinogenesis. This study reveals a novel signaling pathway 
in which syndecan-2 activates PKA via neuroﬁ  bromin and 
PKA consequently phosphorylates Ena/VASP, promoting 
ﬁ  lopodia and spine formation.
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As yet, the molecular mechanism underlying the effect of 
syndecan-2 on cytoskeleton rearrangement remains unclear. 
Although the cytoplasmic domain of syndecan-2 is short ( 30 
  residues) and has no kinase domain, several syndecan-2–inter-
acting proteins have been identifi  ed whose activity may provide 
clues about syndecan-2 signaling. The cytoplasmic domain of 
syndecan-2 consists of three small regions: two highly con-
served regions (C1 and C2) and, between these, a variable (V) 
region unique to each syndecan. The C2 region contains a type II 
PDZ-binding motif (residues E-F-Y-A; Cohen et al., 1998; 
Hsueh et al., 1998). This EFYA motif is important for syndecan-2–
dependent dendritic spine formation, and syndecan-2 loses the 
ability to promote spinogenesis when the C2 motif is removed 
(Ethell and Yamaguchi, 1999). Several adaptor proteins such as 
syntenin, calcium/CaM-dependent serine protein kinase (CASK), 
synbindin, and synectin all bind to the EFYA motif of syndecans 
(Grootjans et al., 1997; Cohen et al., 1998; Hsueh et al., 1998; 
Ethell et al., 2000; Gao et al., 2000), suggesting that these inter-
actions play a role in synaptic formation.
Another syndecan-2–interacting protein is neurofi  bromin 
(Hsueh et al., 2001), which is encoded by the neurofi  bromatosis 
type 1 (NF1) gene and interacts with the C1 region of syndecan-2. 
40–60% of NF1 patients are characterized as having specifi  c 
learning disabilities (for reviews see Rosser and Packer, 2003; 
Acosta et al., 2006). Mice carrying a heterozygous null mutation 
of the NFl gene also show several features of the learning defi  -
cits associated with NF1 mutations in humans (for review see 
Costa and Silva, 2002; Costa et al., 2002). These studies indi-
cate an important role of neurofi  bromin in neuronal function. 
At the molecular level, neurofi  bromin possesses a central Ras 
GTPase-activating protein–related domain that regulates the 
Ras–MAPK pathway (for reviews see Cichowski and Jacks, 2001; 
Zhu and Parada, 2001). In addition, neurofi  bromin is also in-
volved in the cAMP pathway via the regulation of adenylyl cy-
clase through two distinct pathways (Tong et al., 2002; Dasgupta 
et al., 2003; Hannan et al., 2006). One is the receptor tyrosine 
kinase pathway, which acts independently of any heterotrimeric 
G protein; Ras activation by neurofi  bromin is essential for this 
pathway. The other is the classic heterotrimeric G-protein path-
way, which is Gαs dependent and requires the C-terminal region 
of neurofi  bromin (Hannan et al., 2006).
In this study, we elucidate the role of these intracellular 
interactions of syndecan-2 in neuronal morphogenesis. Filopo-
dia formation in nonneuronal cells was chosen here as a model 
to study the early downstream signaling of syndecan-2. The 
common signaling of the syndecan-2–neurofi  bromin–PKA–
  Enabled (Ena)/vasodilator-stimulated phosphoprotein (VASP) 
pathway leading to fi  lopodia formation and spinogenesis was 
then studied in cultured hippocampal neurons. Our study pro-
vides the fi  rst evidence that neurofi  bromin is required for den-
dritic spine formation, which may explain how NF1 mutation 
leads to defi  cits in learning and memory.
Results
Syndecan-2 is essential for dendritic 
spine formation
To confi  rm that syndecan-2 is important for dendritic spine forma-
tion, we used an RNAi approach to reduce neuronal syndecan-2 
protein levels. First, we examined the ability of syndecan-2 small 
hairpin RNA (shRNA) to knock down syndecan-2.   Syndecan-2 
shRNA but not vector control (SUPER.neo+GFP) effi  ciently 
down-regulated syndecan-2 protein expression in both human 
embryonic kidney (HEK) 293T cells and cultured hippocampal 
neurons (Fig. S1, A and B; available at http://www.jcb.org/cgi/
content/full/jcb.200608121/DC1). The effect of syndecan-2 
shRNA on dendritic spine formation was then investigated. 
Constructs expressing syndecan-2 shRNA (also expressing 
GFP) and GFP–actin were cotransfected into hippocampal 
neurons at 11 DIV. Morphology of dendritic protrusions was 
then assessed by GFP and GFP-actin signals. At 16 DIV, den-
dritic spines in our cultures had differentiated and   exhibited 
Figure 1.  Syndecan-2 is important for dendritic spine forma-
tion. (A–C) Cultured hippocampal neurons were cotransfected 
with vector control SNG (pSUPER.neo+GFP) and EGFP-actin 
(DNA ratio 2:1; A), syndecan-2 shRNA and EGFP-actin (DNA 
ratio 2:1; B), and syndecan-2 shRNA, EGFP-actin, and syn-
decan-2 silent mutant resistant to syndecan-2 shRNA (DNA ratio 
6:1:6; C). The GFP and GFP-actin signals were then viewed to 
assess cell morphology. The insets are the magniﬁ  ed images of 
the boxed areas. Bar, 10 μm. (D) Quantitative analysis of the 
effects of syndecan-2 shRNA on spine formation as described 
in Materials and methods. The cumulative probability distribu-
tions of protrusion density along dendrites are shown.SYNDECAN-2 SIGNALING IN SPINOGENESIS • LIN ET AL. 831
characteristics of mature spines (Fig. 1 A, inset). In the presence of 
syndecan-2 shRNA, the number of dendritic protrusions repre-
senting dendritic spines was greatly reduced (Fig. 1, B and D). 
To ensure the sequence-specifi  c effect of syndecan-2 shRNA, 
a syndecan-2 silent mutant insensitive to syndecan-2 shRNA was 
coexpressed with syndecan-2 shRNA (Fig. 1 C). Overexpres-
sion of the silent mutant did rescue the effect of syndecan-2 
shRNA on protrusion number (Fig. 1 D). In addition, mature 
spines were observed along the dendrites in the presence of 
 syndecan-2 mutant (Fig. 1 C, inset). These results support a critical 
role for syndecan-2 in dendritic spine formation.
Because dendritic fi  lopodia have been proposed to be pre-
cursors of dendritic spines and syndecan-2 has been shown to 
induce fi  lopodia formation in nonneuronal cells (Granes et al., 
1999, 2000), it is likely that the overexpression of syndecan-2 in 
cultured hippocampal neurons fi  rst induces fi  lopodia formation 
and then promotes dendritic spine maturation. Indeed, when 
syndecan-2 was transfected into cultured hippocampal neurons 
at 1 DIV, numerous fi  lopodia emerging from dendrites were 
  observed at 4–5 DIV (Fig. 2 C). Because fi  lopodia formation 
induced by syndecan-2 also occurs in nonneuronal cells, this 
initial process involved in dendritic spinogenesis does not ap-
pear to be neuron specifi  c, although the transformation from fi  lo-
podia to spines should be specifi  c for neurons. To explore the 
signaling downstream of syndecan-2 that initiates spine forma-
tion, we fi  rst used fi  lopodia formation in nonneuronal HEK 
cells as a model system for syndecan signaling and confi  rmed 
these observations in cultured hippocampal neurons.
Downstream signaling of syndecan-2
To monitor syndecan-2 expression and cell morphology of trans-
fected cells, we generated the syndecan-2 antibody syndecan-2G. 
Figure 2.  PKA is involved in syndecan-2–induced ﬁ  lo-
podia formation. (A) HEK293T cells were transfected 
with GFP, syndecan-2, or PKI construct as   indicated. 
For cells transfected with syndecan-2, immunostaining 
using the syndecan-2G antibody was performed. For 
cells transfected with GFP, immunostaining was skipped. 
PKA inhibitors KT5720 and H89 were added to 
the culture 16 (O/N), 6, or 3 h before harvesting as 
  indicated. (B) Cumulative probability distributions of 
ﬁ  lopodia density in A were analyzed as described in 
Materials and methods. (C) PKA is involved in syn-
decan-2–induced ﬁ  lopodia in neurons. Syndecan-2, 
GFP, and GFP-actin were transfected into cultured 
hippocampal neurons at 1 DIV. 3–4 d later, cells were 
ﬁ  xed and subjected to immunostaining. H89 (at a 
ﬁ  nal concentration of 10 μM) was added 12 h before 
harvest. (D) Cumulative probability distributions of the 
ﬁ  lopodia density in C. Bars, 10 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  832
This antibody was confi  rmed as recognizing syndecan-2 (Fig. 
S2, A and B; available at http://www.jcb.org/cgi/content/full/
jcb.200608121/DC1) but not syndecan-1, -3, or -4 (Fig. S2 A) in 
both immunoblotting and immunostaining experiments in trans-
fected COS cells, confi  rming its high syndecan-2 specifi  city.
Generally, there are very few fi  lopodia on the surface of 
parental HEK cells (<0.2 fi  lopodia per μm; Fig. 2 B). When 
syndecan-2 was overexpressed in HEK293T cells, numerous 
fi  lopodia were revealed by syndecan-2G antibody (Fig. 2 A). 
Cotransfection of syndecan-2 and GFP into HEK cells was also 
performed (unpublished data). Perhaps as a result of staining of 
the plasma membrane, we found that syndecan-2 signal out-
lined the morphology of HEK cells more clearly than GFP signal. 
To explore the downstream signaling of syndecan-2, several kinase 
inhibitors were added to cultures overexpressing syn  decan-2, 
including the phosphatidylinositol 3-kinase (PI3K) inhibi-
tors LY294002 and wortmannin, PKC inhibitors Go6976 and 
Go6850, and PKA inhibitors KT5720 and H89. Neither PIK3 
nor PKC inhibitors prevented fi  lopodia formation induced by 
syndecan-2 (Fig. S3, available at http://www.jcb.org/cgi/content/
full/jcb.200608121/DC1), suggesting that syndecan-2–induced 
fi  lopodia formation is independent of the PI3K–Akt and PKC 
pathways. In contrast, both PKA inhibitors KT5720 and H89 
decreased syndecan-2–induced fi  lopodia formation (Fig. 2, A 
and B), although the effect of KT5720 was weaker than that of 
H89 for unknown reasons. To further confi  rm that PKA is involved 
in syndecan-2 signaling, a construct expressing the PKA-specifi  c 
peptide inhibitor PKI was cotransfected with syndecan-2 into 
HEK cells. The presence of PKI signifi  cantly reduced the fi  lo  podia 
density on the surface of syndecan-2–expressing HEK293T cells 
(P < 0.001; Fig. 2, A and B), sup  porting the idea that PKA sig-
naling is important for syndecan-2–induced fi  lopodia formation 
in HEK293T cells.
Results for cultured hippocampal neurons were similar to 
those in HEK293T cells: PKA inhibitor H89 effi  ciently reduced 
the number of syndecan-2–induced fi   lopodia along neurites 
(Fig. 2, C and D). These results indicated that syndecan-2 in-
duces dendritic fi  lopodia formation via PKA in cultured hippo-
campal neurons.
Involvement of the syndecan-2 C1 region 
in ﬁ  lopodia formation
A series of C-terminal mutants of syndecan-2 (Fig. 3 A) were 
then used to map the cytoplasmic regions of syndecan-2 that are 
required for fi  lopodia formation. Mutant genes were transfected 
into HEK293T cells, and immunoblotting with syndecan-2G 
 antibody  confi  rmed that expression levels of these mutants were 
comparable with those of wild-type syndecan-2 (Fig. S2 C). In 
addition, these deletions did not considerably affect the plasma 
membrane targeting of mutants (unpublished data). The effects 
of these mutants on fi  lopodia formation in HEK293T cells were 
then examined. The mutant syndecan-2∆3 lacking the last three 
residues of syndecan-2 successfully induced normal fi  lopodia for-
mation (Fig. 3, B and C). The ability of the mutant syndecan-2∆20 
lacking the cytoplasmic V and C2 regions to induce fi  lopodia 
was slightly weaker than that of wild-type syndecan-2 (Fig. 3, 
B and C). When the entire cytoplasmic region of syndecan-2 was 
Figure 3.  The syndecan-2 cytoplasmic C1 region is critical for ﬁ  lopodia 
formation. (A) Amino acid sequences of the rat syndecan-2 constructs. The 
sequences of extracellular (Ex) and transmembrane (TM) domains are not 
shown because of space constraints. The underlining indicates the C1, V, 
and C2 regions. The abilities of each construct to induce ﬁ  lopodia for-
mation and PKA activation are summarized at the right. (B) Wild-type 
syndecan-2 and a series of C-terminal deletion mutants were separately 
transfected into HEK293T cells. Cell morphology was then examined by 
immunoﬂ  uorescent staining using the syndecan-2G antibody. (C) Cumula-
tive probability distributions of the ﬁ  lopodia density in B. (D) Cultured hippo-
campal neurons were transfected with wild-type syndecan-2, -2∆3, and 
-2∆C1. Cell morphology of transfected neurons was analyzed by immuno-
staining using syndecan-2G antibody. (E) Cumulative probability distributions 
of the ﬁ  lopodia density in D. Bars, 10 μm.SYNDECAN-2 SIGNALING IN SPINOGENESIS • LIN ET AL. 833
removed in the syndecan-2∆32 mutant, the ability to form fi  lo-
podia was  greatly impaired (Fig. 3, B and C). In the syndecan-
2∆C1 mutant lacking only the C1 region, the ability to promote 
fi  lopodia formation was also greatly reduced (Fig. 3, B and C). 
These results suggested that both the C1 and V regions (variable 
region of syndecan) of syndecan-2 are involved in fi  lopodia for-
mation in HEK cells, with the C1 region being the most critical.
To confi  rm the role of the syndecan-2 C1 region in den-
dritic fi  lopodia formation, wild-type syndecan-2, -2∆C1, and 
-2∆3 mutants were transfected into cultured hippocampal 
neurons. Compared with wild-type syndecan-2, the number 
of dendritic fi  lopodia was greatly reduced in neurons express-
ing syndecan-2∆C1 (Fig. 3, D and E). In contrast, syndecan-
2∆3 still effi  ciently induced dendritic fi  lopodia formation (Fig. 3, 
D and E). These data supported the notion that the C1 region 
is also critical for syndecan-2–induced fi  lopodia formation 
in neurons.
Because the C1 region of syndecan-2 is the most important 
region for neurofi  bromin interaction and neurofi  bromin is in-
volved in both neurite outgrowth (Yunoue et al., 2003) and 
cAMP signaling, we investigated whether the interaction of neuro-
fi  bromin with the C1 region of syndecan-2 mediates signaling 
from syndecan-2 to PKA. Because mutation of the RKKD motif 
in the C1 region of syndecan-2 impairs neurofibromin inter-
action (Hsueh et al., 2001), we explored this possibility by examin-
ing the effects of the alanine replacement mutants syndecan-2 
RK/AA and KD/AA on fi  lopodia formation. Indeed, the ability 
of syndecan-2 RK/AA and KD/AA mutants to induce fi  lopodia 
formation was much weaker than that of wild type (Fig. 3, B and C), 
suggesting that an interaction with neurofi  bromin is involved in 
fi  lopodia formation induced by syndecan-2.
Dynamic analysis of ﬁ  lopodia
In addition to characterizing fi  lopodia density, we also dynami-
cally analyzed fi  lopodia behavior using time-lapse techniques. 
For syndecan-2–induced fi   lopodia, the motility of fi  lopodia 
was generally very low. The length of most fi  lopodia did not 
change substantially during the time recorded (around 10 min; 
Fig. 4 A): only a small fraction of fi  lopodia was altered in length, 
with a mean velocity of 1.55 ± 0.42 μm/min (Fig. 4 B). In 
contrast, the motility of syndecan-2∆C1–expressing cells was 
higher. Syndecan-2∆C1–induced fi  lopodia frequently extended 
and withdrew at greater amplitudes (Fig. 4 A) and at a mean ve-
locity of 1.86 ± 0.39 μm/min (Fig. 4 B). The majority (12 out 
of 15) of syndecan-2∆C1–induced fi  lopodia extended or with-
drew their tips to lengths >1 μm within 6 min (Fig. 4 C, middle; 
red lines). In contrast, only the minority (3 out of 12) of mobile 
syndecan-2–induced fi  lopodia exhibited this ability (Fig. 4 C, 
top; red lines). When forskolin (FSK), which increases cAMP 
levels, was added into culture transfected with syndecan-2∆C1, 
fi  lopodia movement was immediately frozen (Fig. 4, A and C); 
only a small fraction still extended or withdrew with a mean 
velocity of 1.29 ± 0.26 μm/min (Fig. 4 B), and the movement 
amplitude was <1 μm within 6 min (Fig. 4 C, bottom). These 
results indicated that syndecan-2–induced fi  lopodia are very 
stable and that the PKA pathway may play an important role in 
stabilizing formed fi  lopodia. The relative instability of syndecan-
2∆C1–induced fi  lopodia may account for the lower fi  lopodia 
density shown in Fig. 3 (B and C).
Overexpression of syndecans activates PKA
The aforementioned experiments demonstrated that syndecan-2–
induced fi  lopodia formation was prevented by the addition of PKA 
inhibitors. Thus, it is possible that the overexpression of syndecan-2 
activates PKA and subsequently promotes fi  lopodia formation. 
To test this possibility, we compared PKA activity (measured by 
ELISA) between cells transfected with syndecan-2 or with control 
vector. Syndecan-2 overexpression in HEK293T cells resulted in 
20–30% increases in total PKA activity compared with the vector 
control (Fig. 5). The mutant syndecan-2∆32, which lacked the en-
tire cytoplasmic domain of syndecan-2, lost the ability to enhance 
PKA activity (Fig. 5). The syndecan-2∆C1 mutant missing the 
critical C1 region was also unable to activate PKA (Fig. 5). These 
results support a model for syndecan-2 activation of PKA via its 
cytoplasmic C1 region, culminating in fi  lopodia formation.
Neuroﬁ  bromin is required for ﬁ  lopodia 
formation induced by syndecan-2
To confi  rm that neurofi  bromin mediates signaling from syndecan-2 
to PKA, leading to fi  lopodia formation, we used two  approaches. 
Figure 4.  Time-lapse analysis of ﬁ   lopodia growth in HEK293T cells. 
Syndecan-2 and -2∆C1 mutants were cotransfected with GFP-actin. 18 h after 
transfection, cells were subjected to time-lapse analysis. Dynamics of ﬁ  lo-
podia were monitored by GFP-actin signals. Images were taken every 10 s. 
For syndecan-2∆C1–expressing cells, after a 10-min recording, forskolin 
(FSK) was added into the chamber, and cell morphology was recorded for 
10 more minutes. (A) The representative images for each group. The inter-
vals between each image shown are 1 min. Red asterisks indicate the tips 
of ﬁ  lopodia. Bars, 1 μm. (B) The elongation/withdraw rate of ﬁ  lopodia. 
Each spot indicates one ﬁ  lopodia behavior. (C) Relative positions of ﬁ  lo-
podia tips during the 6-min recording. The tip that moved a distance of >1 μm 
within 6 min is marked in red.JCB • VOLUME 177 • NUMBER 5 • 2007  834
The fi  rst approach was to interrupt the interaction between neuro-
fi  bromin and syndecan-2 by overexpression of the syndecan-2–
  interacting domain of neurofi  bromin, the Jn fragment (residues 
1,356–1,473), which was identifi  ed in a yeast two-hybrid assay 
(Hsueh et al., 2001). Interaction between syndecan and neuro-
fi  bromin Jn fragments was fi  rst confi  rmed under mammalian cell 
culture conditions using coimmunoprecipitation (Fig. S1 D). 
The effect of the Jn fragment on syndecan-2–induced fi  lopodia 
formation was then examined. When the Jn fragment was over-
expressed, fi  lopodia formation induced by syndecan-2 was 
greatly reduced in HEK293T cells (Fig. 6 A). More important, 
the Jn fragment also inhibited fi  lopodia formation in cultured 
hippocampal neurons (Fig. 6, B and C), suggesting an essential 
role for the interaction between syndecan-2 and neurofi  bromin 
in syndecan-2–induced filopodia formation. Overexpression 
of the Jn fragment alone did not cause an obvious morphol-
ogical abnormality of cultured neurons. Neither dendrite number 
nor the length of dendrites was affected by the Jn fragment 
(unpublished data), supporting the specific effect of the Jn 
fragment on syndecan-2–induced filopodia formation. If in-
terrupting the interaction between syndecan-2 and neuro-
fi  bromin by adding the Jn fragment prevents PKA activation 
and, thus, blocks fi  lopodia formation, it can be predicted that 
increasing PKA activity in Jn-expressing cells should restore 
filopodia formation. Indeed, the addition of FSK restored 
filopodia formation impaired by the Jn fragment in both 
HEK293T cells (Fig. 6 A) and cultured hippocampal neurons 
(Fig. 6, B and C).
The second approach to investigate the role of neurofi  bro-
min in syndecan-2–induced fi  lopodia formation was to down-
regulate endogenous neurofi  bromin expression by RNAi. We 
fi  rst examined the down-regulation of endogenous NF1 expression 
using an NF1 shRNA construct (Fig. S1 C). When syndecan-2 
and NF1 shRNA construct were cotransfected into HEK cells, 
the filopodia density was significantly reduced (P < 0.001; 
Fig. 7 A). Similarly, the expression of NF1 shRNA in cultured 
  hippocampal neurons impaired dendritic fi  lopodia formation 
compared with nonsilencer control (Fig. 7, B and C). Again, to 
confi  rm that the effect of NF1 shRNA is to block the signaling 
from syndecan-2 to the cAMP–PKA pathway, FSK was added 
into the cultures transfected with syndecan-2 and NF1 shRNA 
construct. Adding FSK completely restored the fi  lopodia for-
mation in both HEK cells and hippocampal neurons (Fig. 7). 
These results supported the notion that neurofi  bromin medi-
ates signaling to the cAMP–PKA pathway that is required for 
syndecan-2–induced fi  lopodia formation in neurons.
The aforementioned study demonstrated that PKA is the 
important downstream effector of syndecan-2 on the induction   
of fi  lopodia formation. We then wondered whether the activa-
tion of PKA alone is suffi  cient for fi  lopodia formation in cul-
tured hippocampal neurons. To address this point, FSK and 
dibutyryl cAMP were added into young hippocampal neurons 
Figure 5.  Syndecan-2 overexpression activates PKA in HEK293T cells. 
HEK293T cells were transfected with syndecan-2 constructs and the vector 
control as indicated and were harvested for PKA activity assays 18 h after 
transfection. Data shown are the mean ± SEM (error bars) of relative PKA 
activities. Statistical analysis was performed by one-way analysis of vari-
ance to evaluate the difference between the vector control and the speciﬁ  c 
construct (*, P < 0.05; n = 5).
Figure 6.  Disruption of the interaction between syndecan and 
neuroﬁ  bromin prevents syndecan-induced ﬁ  lopodia formation. 
(A and B) Syndecan-2 was cotransfected with the HA-Jn frag-
ment or vector control into HEK293T cells (A) and 1-DIV cultured 
hippocampal neurons (B). FSK (20 μM for HEK cells and 75 μM 
for neurons) was added to the culture 16 (A) or 12 (B) h before 
harvest for immunostaining using syndecan-2G and HA anti-
bodies. Only the syndecan-2 staining patterns are shown. Bars, 
10 μm. (C) Cumulative probability distributions of the ﬁ  lopodia 
density in B.SYNDECAN-2 SIGNALING IN SPINOGENESIS • LIN ET AL. 835
(5 DIV) without the overexpression of syndecan-2. The results 
showed that FSK and dibutyryl cAMP could not induce fi  lo-
podia formation in the absence of syndecan-2 (Fig. 8), suggesting 
that although PKA is required for syndecan-2–induced fi  lopodia 
formation, activation of PKA alone is not suffi  cient for fi  lopodia 
formation. Multiple signaling provided by syndecan-2 may be 
involved in fi  lopodia formation.
Ena/VASP proteins contribute to 
syndecan-2–induced ﬁ  lopodia formation
We then addressed how PKA conducts the signal from syndecan-2/
neurofi  bromin to induce cytoskeleton rearrangement. Previous 
studies had demonstrated that Ena/VASP proteins, which are 
important for the formation and elongation of fi  lopodia, are reg-
ulated by PKA phosphorylation (Aszodi et al., 1999; Hauser 
et al., 1999; Lebrand et al., 2004). There are three related Ena/
VASP proteins in vertebrates—mammalian enabled (Mena), 
VASP, and Ena-VASP–like (EVL)—that are highly related and 
can function interchangeably (Laurent et al., 1999; Geese et al., 
2002; Loureiro et al., 2002). They promote actin fi  lament elon-
gation by interacting with barbed ends and shielding them from 
capping proteins (Bear et al., 2002). Mena, EVL, and VASP all 
share a conserved PKA phosphorylation site, which is critical 
for the regulation of their function in actin fi  lament elongation 
(Loureiro et al., 2002). It has been shown that Mena is present 
at the tip of growth cone fi  lopodia (Lanier et al., 1999), where it 
is positioned to initiate actin polymerization and promote fi  lo-
podia elongation.
To address whether Ena/VASP is the downstream effector 
of the syndecan-2–neurofi  bromain–PKA pathway, we fi  rst ex-
amined whether Ena/VASP proteins are present at the tips of 
syndecan-2–induced fi  lopodia. GFP-Mena, -VASP, and -EVL 
all distributed to the tips of every single fi  lopodia in syndecan-2–
transfected HEK293T cells (Fig. S4 A, available at  http://www
.jcb.org/cgi/content/full/jcb.200608121/DC1) as well as cul-
tured neurons (Fig. 9 A). These results favor the possibility that 
Figure 7.  Knocking down of endogenous neuroﬁ  bromin 
prevents syndecan-2–induced ﬁ  lopodia formation. (A and B) 
HEK293 cells (A) and cultured hippocampal neurons (B) were 
transfected with syndecan-2, the NF1 shRNA, and nonsilencer 
control as indicated. The ratio of syndecan-2 cDNA to shRNA 
construct was 1:2. FSK was added to the cultures to access the 
effect of neuroﬁ   bromin on PKA. (C) Cumulative probability 
distributions of the ﬁ  lopodia densities in B. Bars, 10 μm.
Figure 8.  PKA activation alone does not considerably en-
hance dendritic ﬁ  lopodia formation in cultured hippocampal 
neurons. (A–C) GFP and GFP-actin expression constructs were 
cotransfected into cultured hippocampal neurons at 1 DIV. At 
5 DIV, cells were ﬁ  xed for monitoring morphology. (B and C) 
12 h before ﬁ  xation, FSK (B) and dibutyryl cAMP (db cAMP; 
C) were added into the cultures at a ﬁ  nal concentration of 
75 μM and 1 mM, respectively. (D) Cumulative probability 
distributions of the ﬁ  lopodia density in A–C. Bar, 10 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  836
Ena/VASP proteins are involved downstream of syndecan-2. To 
further explore this possibility, we examined VASP phosphory-
lation at the PKA sites in the presence of syndecan-2. Indeed, 
syndecan-2 overexpression enhanced the phosphorylation levels 
of VASP in HEK293T cells, as revealed by immunoblotting 
using phosphopeptide antibodies specifi  cally recognizing PKA-
phosphorylated VASP (Fig. 9 B). This data supported the acti-
vation of VASP by syndecan-2 overexpression. To address the 
role of Ena/VASP in syndecan-2–induced fi  lopodia formation, 
FP4-mito and AP4-mito constructs were coexpressed with syn-
decan-2 in cells. FP4-mito is a fusion containing EGFP, four 
binding motifs for Ena/VASP proteins, and a mitochondria 
target sequence (Bear et al., 2000). This fusion binds and mis-
targets Ena/VASP protein to mitochondria instead of plasma 
membrane, reducing the fi  lopodia formation activity of Ena/
VASP proteins (Bear et al., 2000; Lebrand et al., 2004). AP4-mito, 
which contains a mutation in the Ena/VASP-binding motif and 
fails to interact with Ena/VASP proteins, was used as a negative 
control. In both HEK293T cells (Fig. S4 B) and cultured hippo-
campal neurons (Fig. 9, C and D), the expression of FP4-mito 
reduced syndecan-2–induced fi  lopodia formation. These results 
supported the notion that Ena/VASP proteins are the downstream 
mediators of syndecan-2. The addition of FSK into the culture 
cotransfected with syndecan-2 and FP4-mito did not prevent the 
blocking effect of FP4-mito in HEK293T cells (Fig. S4 B) or in 
cultured hippocampal neurons (Fig. 9, C and D), supporting the 
idea that PKA works upstream of Ena/VASP.
Neuroﬁ  bromin and Ena/VASP proteins 
are required for dendritic spine formation
The aforementioned results showed that syndecan-2 promotes 
fi  lopodia formation via an NF1–PKA–Ena/VASP pathway in 
both HEK293T cells and cultured hippocampal neurons. To fur-
ther elucidate the involvement of this signaling pathway in den-
dritic spine formation, we performed three more experiments. 
First, we examined the requirement of the cytoplasmic region of 
syndecan-2 in spine formation. Wild-type syndecan-2, -2∆C1, 
and -2∆3 mutants were transfected into cultured hippocampal 
neurons at 1 DIV, and their abilities to induce dendritic spine for-
mation were examined at 8–9 DIV. Consistent with previous 
observations (Ethell and Yamaguchi, 1999), wild-type syndecan-2 
induced dendritic spine formation at 8–9 DIV (Fig. 10 A). These 
spines formed functional synapses because they made contact 
with presynaptic buttons, as revealed by presynaptic marker syn-
aptophysin staining (Fig. 10 A). For neurons transfected with 
syndecan-2∆3, the protrusion density was not signifi  cantly dif-
ferent from that of wild-type syndecan-2 (P = 0.387; Fig. 10, 
A and B). However, the majority of the protrusions of syndecan-
2∆3–expressing neurons still carried the characteristics of fi  lo-
podia (being longer than 2 μm and lacking a head; Fig. 10, A and B), 
supporting the idea that syndecan-2∆3 can promote fi  lopodia 
formation; however, the consequent transformation from fi  lopodia 
to spines was prevented. For syndecan-2∆C1, the density of 
the protrusion was much less than that induced by wild-type 
syndecan-2 (Fig. 10, A and B). This outcome was similar to the 
effect of syndecan-2∆C1 on fi  lopodia formation at 4–5 DIV 
(Fig. 3 D). These results support the notion that the C1 region 
of syn  decan-2 is required for both fi  lopodia and spine formation 
and that the C2 region is critical for spine formation. The fact that 
the protrusion densities induced by syndecan-2 and -2∆3 were 
similar (Fig. 10 B) also supports the hypothesis that fi  lopodia are 
the intermediates of spines in this syndecan-2–dependent process.
Next, we examined the involvement of neurofi  bromin and 
Ena/VASP proteins in spine formation by again expressing NF1 
Figure 9.  Ena/VASP proteins are important for 
syndecan-2 signaling in ﬁ  lopodia  formation.  (A) 
Syndecan-2 was cotransfected with EGFP-Mena, -VASP, 
and -EVL into cultured hippocampal neurons at 1 DIV. 
Cells were harvested for staining using syndecan-2G 
and GFP antibodies at 4–5 DIV. Syndecan-2 was 
viewed by AlexaFluor594 in red; Ena/VASP proteins 
were viewed by AlexaFluor488 in green. (B) Syndecan-2 
overexpression induces VASP phosphorylation. HEK 
cells were transfected with syndecan-2 and vector con-
trol and subjected to immunoblotting using antibodies 
recognizing phosphorylated S157 and S239 of VASP 
and other proteins as indicated. Arrowheads point to 
phosphorylated VASP; the arrow points to unphos-
phorylated VASP. (C) Syndecan-2 was cotransfected 
with the AP4-mito or FP4-mito construct into cultured 
hippocampal neurons. Filopodia formation was moni-
tored using the syndecan-2 staining pattern. (D) Cumu-
lative probability distributions of the ﬁ  lopodia density 
in C. Bars, 10 μm.SYNDECAN-2 SIGNALING IN SPINOGENESIS • LIN ET AL. 837
shRNA and FP4-mito constructs, respectively, in hippocampal 
neurons at 11–12 DIV. The spine density of mature neurons was 
then examined at 16–17 DIV. Compared with nonsilencer con-
trol, the NF1 shRNA construct signifi  cantly reduced spine den-
sity along dendrites of mature hippocampal neurons (P < 0.001; 
Fig. 10, C and D), supporting the role of neurofi  bromin in den-
dritic spine formation. In the investigation targeting Ena/VASP 
proteins, expression of the FP4-mito construct also inhibited spine 
formation in mature hippocampal neurons (Fig. 10, E and F), sup-
porting an involvement of Ena/VASP proteins in spine formation. 
In conclusion, these results indicated that neurofi  bromin and 
Ena/VASP proteins contribute to dendritic spine formation, per-
haps through the regulation of fi  lopodia formation.
Discussion
Using HEK cells and cultured hippocampal neurons as models, 
we have demonstrated that the neurofi  bromin–PKA–Ena/VASP 
pathway mediates the downstream signaling of syndecan-2. 
This study shows that syndecan-2 itself can deliver a signal to 
cells to change cell morphology. Our results also provide the 
fi  rst evidence that both neurofi  bromin and Ena/VASP proteins 
are involved in dendritic spine formation.
For cell signaling, syndecans are fi  rst identifi  ed as co-
receptors for growth and differentiation factors. However, the pre-
vious studies indicated that syndecans are capable of activating 
intracellular signaling pathways directly via their short cytoplasmic 
domains. The fi  rst example of this was seen with syndecan-4; 
overexpression of this protein in CHO cells promotes focal 
adhesion assembly (Longley et al., 1999). The V region of 
syndecan-4, which binds to phosphatidylinositol-4,5-bisphosphate 
and activates PKCα, is critical for this function (Oh et al., 
1998). Another study showed that the pleiotrophin/heparin-
binding growth-associated molecule, which promotes neurite 
outgrowth in developing neurons, binds to syndecan-3 to induce 
a syndecan-3–Src–cortactin interaction (Kinnunen et al., 1998). 
In the present study, we have demonstrated a third signaling 
pathway involving a direct interaction of syndecan-2 with the 
neurofi  bromin–PKA–Ena/VASP pathway. Overexpression of 
syndecan-2 induces fi  lopodia formation via PKA activity, which 
is mediated by neurofi  bromin, and thus regulates the function 
of Ena/VASP proteins in fi  lopodia formation. In contrast to the 
Figure 10. The  syndecan-2–neuroﬁ  bromin–Ena/VASP  sig-
naling pathway is involved in dendritic spinogenesis. (A, C, 
and E) Dissociated hippocampal neurons were transfected 
with syndecan-2, -2△3, or -2△C1 at 1–2 DIV and ﬁ  xed at 
8–9 DIV for immunostaining (A). They were also cotransfected 
with EGFP-actin and nonsilencer or NF1 shRNA (C) and ei-
ther DsRed-actin or myc-actin and AP4-mito or FP4-mito at 
11–12 DIV and ﬁ  xed at 16–17 DIV (E). In A, immunostaining 
using syndecan-2G antibodies was performed to outline the 
cellular morphology of transfected neurons. Two representa-
tive images are shown. For syndecan-2–expressing neurons, 
double staining with the presynaptic marker synaptophysin 
(SVP38) was performed. Some of the syndecan-2–induced 
dendritic spines were adjacent to the SVP38-positive signal, 
which are marked by arrowheads. In C and E, the EGFP-, 
DsRed-, or myc-actin patterns were viewed to assess cell mor-
phology. (B) Cumulative probability distributions of A showing 
the effects of the syndecan-2 cytoplasmic domain on the length 
and density of dendritic spines. (D) Cumulative probability 
distributions of C showing the effect of NF1 shRNA on den-
dritic spine density. (F) Cumulative probability distributions of 
E showing the effects of FP4-mito on spine density. Bars, 2 μm.JCB • VOLUME 177 • NUMBER 5 • 2007  838
heparin-binding growth-associated molecule–syndecan-3 pathway, 
the need for a specifi  c ligand for the activation of syndecan-2 has 
not been clarifi  ed. In our system, overexpression of syndecan-2 
is suffi  cient to induce downstream signaling; however, it cannot 
be ruled out that an unknown syndecan-2 ligand is present in our 
culture systems.
Currently, it is also unclear how the overexpression of 
syndecan-2 enhances the ability of neurofi  bromin to activate 
PKA. Perhaps interaction with syndecan-2 changes the confor-
mation of neurofi  bromin, allowing the activation of adenylyl 
cyclase. Because syndecans form dimers (and perhaps multimers) 
via their transmembrane domains and there are two separate 
syndecan-2–interacting sites in neurofi  bromin (Hsueh et al., 
2001), a single neurofi  bromin molecule may simultaneously in-
teract with a syndecan-2 dimer. This interaction might fi  x the 
neurofi  bromin molecule in a conformation that favors the acti-
vation of adenylyl cyclase. Therefore, increases in the level of 
syndecan-2 might fi  x more neurofi  bromin molecules in a con-
formation that activates adenylyl cyclase. More investigation is 
needed to explore this possibility.
The deletion analyses showed that syndecan-2∆32 and 
-2∆C1 mutants were unable to promote fi  lopodia formation. 
Retention of mutants in the cytoplasm cannot explain this pheno-
type. Our syndecan-2G antibody recognized the ectodomain 
of syndecan-2 (unpublished data). It stained both syndecan-2– 
and -2∆32–expressing cells in the absence of permeabilization 
(unpublished data), indicating the normal surface expression 
of syndecan-2∆32. Moreover, the expression levels of both 
syndecan-2∆C1 and -2∆32 were comparable with that of wild-
type syndecan-2 (Fig. S2 C). The loss of fi  lopodia formation 
with these mutants is also unlikely to be the result of defects in 
protein expression or subcellular distribution. It suggests that 
the regions missing in these deletion constructs are important for 
fi  lopodia formation.
The current fi  ndings indicate that the PKA pathway is 
essential for syndecan-2–induced fi  lopodia formation. However, 
PKA activation itself is not suffi  cient for fi  lopodia formation. It 
suggests that syndecan-2 overexpression is likely to activate mul-
tiple signaling pathways that are all required for dendritic spine 
formation. Consistent with this speculation, the Ras pathway, 
which is also regulated by neurofi  bromin, has been shown to 
contribute to dendritic spine formation (Wu et al., 2001; Vazquez 
et al., 2004; Kumar et al., 2005). It is possible that the Ras and 
PKA pathways downstream of syndecan-2/neurofi  bromin co-
ordinate and regulate dendritic spinogenesis. Alternatively, the 
ectodomain of syndecan-2 involved in cell–cell or cell–matrix 
interaction may also be essential for fi  lopodia outgrowth. With-
out adhesion via the syndecan-2 ectodomain, fi  lopodial protru-
sions may not be stable. The observation that overexpression of 
the entire cytoplasmic domain of syndecan-2 failed to promote 
fi  lopodia formation (unpublished data) also supports the idea that 
the ectodomain of syndecan-2 is required in this process. More 
investigations are required to resolve this issue.
Although the cytoplasmic domain of syndecan-2 is short, 
it interacts with several proteins. Even the complex formation of 
neurofi  bromin, syndecan, and CASK has been shown. How-
ever, it is unclear whether there is any cross talk between CASK 
and neurofi  bromin. CASK apparently has no infl  uence on the 
fi  lopodia formation activity of neurofi  bromin because deletion 
of the CASK-binding site (EFYA motif) on syndecan-2 did not 
affect fi  lopodia formation. Instead of being part of the same 
process, it seems likely that the complex formation of CASK, 
syndecan-2, and neurofi  bromin serves to achieve two sequential 
processes: fi  lopodia formation and dendritic spine maturation. 
The interaction of syndecan-2 with neurofi  bromin initiates fi  lo-
podia formation, and the interaction with CASK may further 
transform fi  lopodia to dendritic spines. The results of the analy-
sis of cytoplasmic deletion mutants of syndecan-2 in fi  lopodia 
and spine formation support this speculation.
Ethell et al. (2001) demonstrated that EphB2 receptor tyro-
sine kinase phosphorylates the tyrosine residues Y189 and Y201 
in the C1 and V regions of syndecan-2, respectively. EphB2 
phosphorylation is required for syndecan-2 clustering on den-
drites and the induction of mature spines. When both of the resi-
dues Y189 and Y201 are mutated, the mutant syndecan-2 proteins 
no longer cluster and promote spinogenesis (Ethell et al., 2001). 
However, EphB2 phosphorylation seems only to affect spine for-
mation but not fi  lopodia formation because fi  lopodia formation 
is not affected in neurons expressing syndecan-2 Y189F/Y201F 
mutant (Ethell et al., 2001). In addition, overexpression of an 
EphB2 kinase-dead mutant in hippocampal neurons prevents 
spine but not fi  lopodia formation (Ethell et al., 2001). In addition 
to tyrosine phosphorylation, the V region of the syndecan-2 
cytoplasmic domain contains two PKC phosphorylation sites. 
Xenopus laevis syndecan-2 is phosphorylated by PKC and is 
critical for establishing left-right asymmetry during early devel-
opment (Kramer et al., 2002). However, PKC inhibitors did not 
prevent fi  lopodia formation induced by syndecan-2, suggesting 
that PKC phosphorylation on the V region only regulates the 
function of syndecan-2 at an early embryonic stage for left-right 
decision. Neither EphB2 nor PKC phosphorylation regulates 
syndecan-2–induced fi  lopodia formation.
In conclusion, our studies show clearly that syndecan-2 
plays an active role in delivering a biochemical signal into 
cells. Syndecan-2 remodels the cytoskeleton and promotes 
the formation of fi  lopodia via the neurofi  bromin–PKA–Ena/
VASP pathway.
Materials and methods
Hippocampal neuronal culture and analysis of dendritic 
ﬁ  lopodia/spine formation
Hippocampal neuronal cultures were performed as described previ-
ously (Wang et al., 2004; Lin et al., 2006) with the minor modiﬁ  cation 
that 300,000 cells per well were plated in 12-well plates containing 
poly-L-lysine–coated coverslips in each well. Transfection using calcium 
phosphate precipitation was performed to deliver the plasmid DNA 
into neurons. To study the effect of syndecan-2 on ﬁ  lopodia  formation, 
transfection of syndecan-2 was performed at 1–2 DIV, and immunostain-
ing was performed at 4–5 DIV. Filopodia formation was determined by 
the density of protrusions emerging from neurites with a length between 
0.75 and 10 μm. The protrusions longer than 10 μm were recognized 
as dendritic branches. To study the effect of syndecan-2 on spine forma-
tion at 8–9 DIV, the length of individual protrusions and protrusion density 
were measured. Only the protrusions longer than 0.5 μm were counted. 
To study intrinsic dendritic spine formation, transfection was performed at 
11–12 DIV, and immunoﬂ  uorescence staining was performed at 16–17 
DIV. The densities of protrusions longer than 0.5 μm were determined. SYNDECAN-2 SIGNALING IN SPINOGENESIS • LIN ET AL. 839
All results were shown in cumulative probability distribution and statisti-
cally analyzed using the Kolmogorov-Smirnov test. Signiﬁ  cance  was 
determined based on the D and corresponding p-values. All of the data 
obtained in Kolmogorov-Smirnov tests and sample sizes of each experi-
ment are summarized in the supplemental text (available at http://www
.jcb.org/cgi/content/full/jcb.200608121/DC1).
Transfection of COS and HEK cells, immunoblotting, immunoprecipitation, 
and analysis of ﬁ  lopodia density
The details for transfection of COS cells and immunoblotting of syndecan-2 
and neuroﬁ   bromin have been previously described (Hsueh and Sheng, 
1999a,b; Hsueh et al., 2001). The conditions for HEK293T cell transfection 
using LipofectAMINE (Invitrogen) were identical to those used for COS 
cells. Immunoprecipitation using COS cell extract was performed as de-
scribed previously (Hsueh and Sheng, 1999b) with some modiﬁ  cations. In 
brief, 1 d after transfection, cells were washed twice in PBS and treated with 
2 mM dithiobis[succinimidylpropionate] (Pierce Chemical Co.) in PBS at 
37°C for 30 min. Free dithiobis[succinimidylpropionate] was then removed 
by washing twice with PBS. Cells were lysed with radioimmunoprecipitation 
assay buffer and immunoprecipitated using syndecan-2G antibody. To de-
termine the ﬁ  lopodia density on HEK cell, 24 h after transfection, cells were 
harvested for immunostaining using syndecan-2G antibodies. Filopodia re-
vealed by syndecan-2G signals on the cell surface were counted and di-
vided by the length of cell circumference. For each treatment, a ﬁ  lopodia 
density of >50 cells was measured. Cumulative probability distribution was 
shown, and the Kolmogorov-Smirnov test was used to check the signiﬁ  cance. 
All of the data obtained in Kolmogorov-Smirnov tests and sample sizes of 
each experiment are summarized in the supplemental text.
Antibodies
A rabbit polyclonal syndecan-2 antibody (syndecan-2G) was generated 
using a GST–syndecan-2 (residues 33–211) recombinant protein as antigen. 
The antibody was afﬁ  nity puriﬁ  ed using protein A–Sepharose. The monoclonal 
antibody against GFP was purchased from Invitrogen. VASP antibody was 
obtained from BD Biosciences. Antibodies against phosphorylated S157 
and S239 of VASP were purchased from Chemicon.
Immunoﬂ  uorescence analysis and time-lapse study
Cells were washed twice in PBS and ﬁ  xed in PBS containing 4% PFA and 
4% sucrose for 10 min at room temperature. After washing, HEK cells were 
blocked with 1% BSA/1% normal horse serum, and cultured neurons were 
blocked with 10% BSA for 1 h. The primary antibody was diluted in PBS 
containing 0.5% BSA for HEK and PBS containing 3% BSA for neurons 
and was added to cells for a further 1–2-h incubation. After washing, the 
AlexaFluor488- or -594–conjugated secondary antibody  (Invitrogen) was 
added and incubated for 1–2 h. Samples were then analyzed at room 
temperature with either a ﬂ  uorescence microscope (DM RE; Leica) with a 
PLAPO 63× NA 1.32 oil objective lens (Leica) or a confocal microscope 
(LSM510; Carl Zeiss MicroImaging, Inc.) with a plan-Apochromat 63× 
NA 1.25 oil objective lens (Carl Zeiss MicroImaging, Inc.). For regular ﬂ  uor-
escence microscopy, images were acquired with a cooled CCD camera 
(RTE/CCD-1300-Y/HS; Roper Scientiﬁ  c) operated using MetaMorph soft-
ware (Molecular Devices). For confocal microscopy, the images were 
  acquired using a laser-scanning microscope system (LSM510; Carl Zeiss 
MicroImaging, Inc.). Results were then processed for publication using Photo-
shop software (Adobe) with a minimal adjustment of brightness or contrast 
applied to the whole images.
For the time-lapse study, syndecan-2 and GFP-actin were cotrans-
fected into HEK293T cells at a ratio of 8:1. 18 h after transfection, the dy-
namic of syndecan-2–induced ﬁ  lopodia was monitored by GFP-actin pattern 
in an open chamber under a ﬂ  uorescence microscope (DMRE; Leica) with an 
HCX APO 63× 0.90-W water objective lens. Images were acquired with 
the Roper Scientiﬁ  c cooled CCD camera for at least 10 min. The velocity of 
the ﬁ  lopodia movement and positions of the ﬁ  lopodia tips were analyzed by 
MetaMorph software.
Construction of plasmids
Plasmid construction for the mammalian expression of syndecans 1–4 has 
been previously described (Hsueh et al., 1998). EGFP-Mena, EGFP-VASP, 
EGFP-EVL, FP4-mito, and AP4-mito constructs (Bear et al., 2000; Loureiro 
et al., 2002) were provided by F.B. Gertler (Massachusetts Institute of Tech-
nology, Cambridge, MA). PKI construct was provided by H.-M. Shih (Institute 
of Biomedical Science, Academia Sinica, Taipei, Taiwan).
To construct the C-terminal deletion mutants syndecan-2∆3, -2∆20, 
and -2∆32, the respective syndecan-2 cDNA fragments were PCR ampli-
ﬁ  ed and subcloned into the EcoRI site of the vector GW1-cytomegalovirus. 
The same sense oligonucleotide primer (5′-C  G  G  A  A  T  T  C  A  T   C  G  G  G  T  A  C  G  A-
G  C  C  A  C  G  -3′) was used for PCR construction of all three mutants. The anti-
sense oligonucleotide primers were as follows: (1) for syndecan-2∆3, 
5′-C  G  G  A  A  T  T  C  C  T  A  C  T  C  C  T  T  A  G  T  G  G  G  T  G  C  C  T  T  C  T  -3′; (2) for syndecan-
2∆20, 5′-C  G  G  A  A  T  T  C  C  T  A  A  A  G  G  T  C  G  T  A  G  C  T  T  C  C  T  T  C  G  T  C  T  T  T  C  T  T  C  -3′; and 
(3) for syndecan-2∆32, 5′-C  G  G  A  A  T  T  C  C  T  A  G  T  A  C  A  C  C  A  A  C  A  A  C  A  G  G  A  T-
G  A  G  -3′. The underlined sequences are EcoRI sites that were appended for 
cloning purposes. To construct the syndecan-2∆C1 mutant, a pair of prim-
ers (5′-C  G  G  G  T  A  C  C  A  T  G  C  G  G  G  T  A  C  G  A  G  C  C  A  C  G  -3′ and 5′-G  T  A  C  A  C  C  A-
A  C  A  A  C  A  G  G  A  T  G  A  G  -3′) were used to amplify the region containing the 
extracellular and transmembrane domains. A pair of primers (5′-G  A  C  C  T  T-
G  G  A  G  A  A  C  G  C  A  A  A  C  C  G  -3′ and 5′-C  G  G  A  A  T  T  C  T  T  A  T  G  C  A  T  A  A  A  A  C  T  C  C  T  T-
A  G  T  -3′) was used to amplify the variable and C2 domains. These two 
fragments were ligated by blunt-end ligation and subcloned into the KpnI 
and EcoRI sites of the vector GW1-cytomegalovirus. A QuikChange XL 
Site-Directed Mutagenesis kit (Stratagene) was used for generating the 
syndecan-2 RK/AA, KD/AA, and silent mutants. For syndecan-2 RK/AA, the 
pair of primers 5′-G  T  T  G  G  T  G  T  A  C  C  G  C  A  T  G  G  C  G  G  C  G  A  A  A  G  A  C  G  A  A  G  G  A-
A  G  C  T  A  C  -3′ and 5′-G  C  T  T  C  C  T  T  C  G  T  C  T  T  T  C  G  C  C  G  C  C  A  T  G  C  G  G  T  A  C  A  C  C  A-
A  C  A  A  C  -3′ was used for site-directed mutagenesis. For syndecan-2 KD/AA, 
the primers 5′-G  T  A  C  C  G  C  A  T  G  C  G  G  A  A  G  G  C  A  G  C  C  G  A  A  G  G  A  A  G  C  T  A  C  G-
A  C  C  T  T  G  -3′ and 5′-G  T  C  G  T  A  G  C  T  T  C  C  T  T  C  G  G  C  T  G  C  C  T  T  C  C  G  C  A  T  G  C  G  G  T-
A  C  A  C  -3′ were used. For the syndecan-2 silent mutant, the pair of primers 
5′-A  G  C  A  G  C  T  C  C  A  T  T  G  A  G  G  A  A  G  C  T  T  C  A  G  G  G  T  T  G  T  A  T  C  C  T  A  T  T  G  -3′ and 
5′-C A  A  T  A  G  G  A  T  A  C  A  A  C  C  C  T  G  A  A  G  C  T  T  C  -3′ was used. The underlined 
residues indicate the mutated sites.
For vector-based syndecan-2 RNAi construction, a pair of oligo-
nucleotides (syndecan-2is, 5′-G  A  T  C  C  C  C  G  C  T  T  C  A  G  G  A  T  T  A  T  A  T  C  C  T  A  T  T  C-
A  A  G  A  G  A  T  A  G  G  A  T  A  T  A  A  T  C  C  T  G  A  A  G  C  T  T  T  T  T  G  G  A  A  A  -3′; syndecan-2iAs, 
5′-G  C  T  T  T  T  C  C  A  A  A  A  A  G  C  T  T  C  A  G  G  A  T  T  A  T  A  T  C  C  T  A  T  C  T  C  T  T  G  A  A  T  A  G  G  A  T  A  T  A-
A  T  C  C  T  G  A  A  G  C  G  G  G  -3′) was annealed and inserted into the BgIII and HindIII 
sites of the siRNA expression vector pSUPER.neo+GFP (OligoEngine). The 
underlined residues correspond to the nucleotide residues 148–166 of rat 
syndecan-2 cDNA. The NF1 shRNA expression constructs 27 and 32 in 
vector pSM2c were purchased from Open Biosystems and corresponded to 
the nucleotide residues 8,416–8,436 and 3,349–3,370 of human type I 
NF1, respectively. Because residues 8,416–8,436 are identical in the 
human and rat NF1 genes, construct 27 can also knock down rat NF1. 
Nonsilencer control expressing and shRNA sharing no homology with any 
known mammalian genes were also purchased from Open Biosystems. 
The Jn and Pn mammalian expression constructs were created by excising 
the Jn and Pn fragments from the Jn-pGAD10 and Pn-pGAD10 constructs 
(Hsueh et al., 2001) with EcoRI and subcloning them into the EcoRI site of 
a modiﬁ  ed vector GW1 containing a myc cassette. Plasmids EGFP and 
EGFP-actin were purchased from CLONTECH Laboratories, Inc. For myc-
tagged actin, actin cDNA was digested from EGFP-actin and subcloned 
into the BglII site of the vector myc-GW1.
PKA activity assay
HEK293T cells were transfected with the vector control or a variety of 
syndecan-2 constructs. 18 h after transfection, cells were harvested for PKA 
activity analysis using an ELISA kit from Calbiochem. Equal protein amounts 
of cell extracts were used.
Animals and housing
All animal experiments were performed with the approval of and in strict 
accordance with the guidelines of the Academia Sinica Institutional Ani-
mal Care and Utilization Committee and the Republic of China Council of 
Agriculture Guidebook for the Care and Use of Laboratory Animals. Preg-
nant rats were housed individually and killed by CO2 inhalation. All efforts 
were made to minimize animal suffering and to reduce the number of ani-
mals required.
Online supplemental material
Fig. S1 is the characterization of syndecan-2 and neuroﬁ  bromin RNAi 
constructs and the dominant-negative mutant of neuroﬁ  bromin. Fig. S2 
shows the speciﬁ  city of syndecan-2 antibody and expression of syndecan-2 
wild-type and mutant constructs. Fig. S3 shows that PKC and PI3K are 
not involved in ﬁ  lopodia formation downstream of syndecan-2. Fig. S4 
shows that Ena/VASP proteins are the downstream effectors of PKA acti-
vated by syndecan-2 in HEK293T cells. Supplemental text contains the data 
obtained in Kolmogorov-Smirnov tests, including D and corresponding p-values 
and sample sizes of each experiment. Online supplemental material is 
available at http://www.jcb.org/cgi/content/full/jcb.200608121/DC1.JCB • VOLUME 177 • NUMBER 5 • 2007  840
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